Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions.
OBJECTIVE
Reduction of melanocortin signaling in the brain results in obesity. However, where in the brain reduced melanocortin signaling mediates this effect is poorly understood.


METHODS
We determined the effects of long-term inhibition of melanocortin receptor activity in specific brain regions of the rat brain. Melanocortin signaling was inhibited by injection of a recombinant adeno-associated viral (rAAV) vector that overexpressed Agouti-related peptide (AgRP) into the paraventricular nucleus (PVN), the ventromedial hypothalamus (VMH), the lateral hypothalamus (LH) or the accumbens shell (Acc).


RESULTS
Overexpression of AgRP in the rat PVN, VMH or LH increased bodyweight, the percentage of white adipose tissue, plasma leptin and insulin concentrations and food intake. Food intake was mainly increased because of an increase in meal size in the light and dark phases, after overexpression of AgRP in the PVN, LH or VMH. Overexpression of AgRP in the PVN or VMH reduced average body core temperature in the dark on day 40 post injection, whereas AgRP overexpression in the LH did not affect temperature. In addition, overexpression of AgRP in the PVN, LH or VMH did not significantly alter mRNA expression of AgRP, neuropeptide Y (NPY), pro-opiomelanocortin (POMC) or suppressor of cytokine signaling 3 (SOCS3) in the arcuate. Overexpression of AgRP in the Acc did not have any effect on the measured parameters.


CONCLUSIONS
Reduction of melanocortin signaling in several hypothalamic regions increased meal size. However, there were brain area-specific effects on other parameters such as core temperature and plasma leptin concentrations. In a previous study, where NPY was overexpressed with an rAAV vector in the PVN and LH, meal frequency and meal size were increased respectively, whereas locomotor activity was reduced by NPY overexpression at both nuclei. Taken together, AgRP and NPY have complementary roles in energy balance.
de Backer
M W A
MW
Rudolf Magnus Institute of Neuroscience, Department of Neuroscience and Pharmacology, Utrecht University Medical Centre Utrecht, Utrecht, The Netherlands.
la Fleur
S E
SE
Brans
M A D
MA
van Rozen
A J
AJ
Luijendijk
M C M
MC
Merkestein
M
M
Garner
K M
KM
van der Zwaal
E M
EM
Adan
R A H
RA
D054369:Agouti-Related Protein / Q000378:metabolism*; D000818:Animals; D001835:Body Weight / Q000502:physiology*; D002460:Cell Line; D004435:Eating / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology*; D007026:Hypothalamic Area, Lateral / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism* / Q000502:physiology; D008297:Male; D020644:Midline Thalamic Nuclei / Q000378:metabolism; D009714:Nucleus Accumbens / Q000378:metabolism; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology; D051381:Rats; D017208:Rats, Wistar; D044101:Receptors, Melanocortin / Q000037:antagonists & inhibitors / Q000502:physiology*; D014697:Ventromedial Hypothalamic Nucleus / Q000378:metabolism
D054369:Agouti-Related Protein; D044101:Receptors, Melanocortin